NextCure - Stock Price History | NXTC

Historical daily share price chart and data for NextCure since 2021 adjusted for splits. The latest closing stock price for NextCure as of September 24, 2021 is 7.05.
  • The all-time high NextCure stock closing price was 92.22 on November 05, 2019.
  • The NextCure 52-week high stock price is 14.40, which is 104.3% above the current share price.
  • The NextCure 52-week low stock price is 6.70, which is 5% below the current share price.
  • The average NextCure stock price for the last 52 weeks is 9.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
NextCure Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 24.1227 55.6800 58.3700 8.1500 10.9000 -80.65%
2019 30.6936 19.9000 92.2200 14.1600 56.3300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.190B $0.022B
NextCure Inc. is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing immunomedicines to treat cancer and other immune-related diseases. The company's product candidate consists of NC318 and NC410 which are in clinical stage. NextCure Inc. is based in Beltsville, Maryland.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71